The following is a summary of “GATA3 amplification is associated with high grade disease in non-invasive urothelial bladder cancer but unrelated to patient prognosis,” published in the February 2025 ...

Gene's lead asset shows high complete response rates in BCG-unresponsive NMIBC patients. Click here to read why ENGN stock is ...

New AUA microhematuria guideline incorporates language for urine-based biomarkers in appropriately counseled ...

In the case of Respiri (ASX:RSH), the ‘connected care’ operator is about to adopt its third name – Vitasora – after raising ...

brachytherapy for patients with intermediate risk prostate cancer. Risk of Secondary Bladder Cancer After High Dose Rate Brachytherapy ... Ultrasound For Locally Recurrent Prostate Cancer after ...

Discover a study that found that the combination of durvalumab and tremelimumab with concurrent radiotherapy is a feasible ...

The popular golfer admits that its hard for him to set goals after all, considering that the battle with this disease can be ...

Gall bladder cancer is a type of tumour that begins in the gall bladder, the organ located on the right side of the abdomen that stores bile, a digestive fluid produced by the liver. The most ...

Increase seen in number of acute care visits, hospice use, palliative care, advanced care planning from six months before to month of death ...

Burning Rock Biotech Limited’s BNR share price has dipped by 13.08%, which has investors questioning if this is right time to buy.

The subtypes investigated in bladder cancer were CK19, CK20 and CK7 IHC/RT-PCR CK20: 56–46% [98,99]; CK7: 100% [99]; CK1: 93.1% [101] Association of CK19 with UPII detected pN0 patients with ...